Fundraising Fox

Synvivia

YC S16

San Francisco, US · Delaware corporation · 4 employees · 3 known investors

Synvivia engineers molecules designed to reprogram cells. The company operates in the biotech sector.

Founders & leadership· Y Combinator alumni (S16)

GLGabriel Lopez
Gabriel LopezinFounder/CEOGabriel Lopez is founder and CEO of Synvivia, a biotech company that develops technology for biopharmaceutical manufacturing optimization.

Investors · 3

Reported raises · per SEC filings

Form D private placements

$54.1K disclosed across 1 round · 2023

$54.1KraisedDec 2023 · 1 investors · Biotechnology
Rule 506(c)
Officers, directors & promoters on the filing
  • Gabriel LopezExecutive Officer, Director
Offering amount
$54.1K
Amount sold
$54.1K
First sale
Dec 2023
Incorporated
Corporation, Delaware
Federal exemptions
06c
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Science FoundationPhase I2022$255.9K
National Institutes of Health (NIH)National Institutes of HealthPhase I2016$295.2K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Synvivia do?
Synvivia engineers molecules designed to reprogram cells. The company operates in the biotech sector.
Who founded Synvivia?
Synvivia was founded by Gabriel Lopez.
Who are Synvivia's investors?
Synvivia's investors include Creative Ventures, Metaplanet, Y Combinator.
How much funding has Synvivia raised?
Synvivia has disclosed $54.1K raised across 1 round.
Where is Synvivia headquartered?
Synvivia is headquartered in San Francisco, US.